Literature DB >> 10529171

Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.

S Hemmerich1, C Paavola, A Bloom, S Bhakta, R Freedman, D Grunberger, J Krstenansky, S Lee, D McCarley, M Mulkins, B Wong, J Pease, L Mizoue, T Mirzadegan, I Polsky, K Thompson, T M Handel, K Jarnagin.   

Abstract

The CC chemokine, MCP-1, has been identified as a major chemoattractant for T cells and monocytes, and plays a significant role in the pathology of inflammatory diseases. To identify the regions of MCP-1 that contact its receptor, CCR2, we substituted all surface-exposed residues with alanine. Some residues were also mutated to other amino acids to identify the importance of charge, hydrophobicity, or aromaticity at specific positions. The binding affinity of each mutant for CCR2 was assayed with THP-1 and CCR2-transfected CHL cells. The majority of point mutations had no effect. Residues at the N-terminus of the protein, known to be crucial for signaling, contribute less than a factor of 10 to the binding affinity. However, two clusters of primarily basic residues (R24, K35, K38, K49, and Y13), separated by a 35 A hydrophobic groove, reduced the level of binding by 15-100-fold. A peptide fragment encompassing residues 13-35 recapitulated some of the mutational data derived from the intact protein. It exhibited modest binding as a linear peptide and dramatically improved affinity when the region which adopts a single turn of a 3(10)-helix in the protein, which includes R24, was constrained by a disulfide bond. Additional constraints at the ends of the peptide, corresponding to the disulfide between the first and third cysteines in MCP-1, yielded further improvements in affinity. Together, these data suggest a model in which a large surface area of MCP-1 contacts the receptor, and the accumulation of a number of weak interactions results in the 35 pM affinity observed for the wild-type (WT) protein. The receptor binding site of MCP-1 also is significantly different from the binding sites of RANTES and IL-8, providing insight into the issue of receptor specificity. It was previously shown that the N-terminus of CCR2 is critical for binding MCP-1 [Monteclaro, F. S., and Charo, I. F. (1996) J. Biol. Chem. 271, 19084-92; Monteclaro, F. S., and Charo, I. F. (1997) J. Biol. Chem. 272, 23186-90]. Point mutations of six acidic residues in this region of the receptor were made to test their role in ligand binding. This identified D25 and D27 of the DYDY motif as being important. On the basis of our data, we propose a model in which the receptor N-terminus lies along the hydrophobic groove in an extended fashion, placing the DYDY motif near the basic cluster involving R24 and K49 of MCP-1. This in turn orients the signaling residues (Y13 and the N-terminus) for productive interaction with the receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529171     DOI: 10.1021/bi991029m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  49 in total

1.  Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.

Authors:  Thu Trang Thi Vu; Bon-Kyung Koo; Jung-A Song; Seon-Ha Chong; Cho Rong Park; Minh Tan Nguyen; Boram Jeong; Han-Bong Ryu; Jae Young Seong; Yeon Jin Jang; Robert Charles Robinson; Han Choe
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

2.  Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.

Authors:  Stefanie Thiele; Anne Steen; Pia C Jensen; Jacek Mokrosinski; Thomas M Frimurer; Mette M Rosenkilde
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

Review 3.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

Authors:  C L Salanga; T M Handel
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

4.  Characterization of a novel modification of a CHO-produced mAb: Evidence for the presence of tyrosine sulfation.

Authors:  Jia Zhao; Jason Saunders; Svetlana Dukleska Schussler; Sandra Rios; Francis Kobina Insaidoo; Aleksandr L Fridman; Huijuan Li; Yan-Hui Liu
Journal:  MAbs       Date:  2017 Aug/Sep       Impact factor: 5.857

5.  Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.

Authors:  India C Severin; Jean-Philippe Gaudry; Zoë Johnson; Andreas Kungl; Ariane Jansma; Bernd Gesslbauer; Barbara Mulloy; Christine Power; Amanda E I Proudfoot; Tracy Handel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

6.  Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor.

Authors:  B T Seet; R Singh; C Paavola; E K Lau; T M Handel; G McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

7.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Authors:  Amanda E I Proudfoot; Tracy M Handel; Zoë Johnson; Elaine K Lau; Patricia LiWang; Ian Clark-Lewis; Frédéric Borlat; Timothy N C Wells; Marie H Kosco-Vilbois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

8.  Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors.

Authors:  Bruce T Seet; Catherine A McCaughan; Tracy M Handel; Andrew Mercer; Craig Brunetti; Grant McFadden; Stephen B Fleming
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids.

Authors:  Bin Liu; Eric Wilson
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

Review 10.  Chemokines and their receptors: insights from molecular modeling and crystallography.

Authors:  Irina Kufareva
Journal:  Curr Opin Pharmacol       Date:  2016-07-25       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.